Global Health Ltd.
Snapshot View

View in App

Prices View details >>

524.00 +12.70 ▲2.5%

31 March 2023, 04:01:00 PM
Volume: 29,170

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.medanta.org
Market Cap 14,111.09 Cr.
Enterprise Value(EV) 14,437.14 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 7.32 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 71.63 Trailing Twelve Months Ending 2022-03
Industry PE 46.34 Trailing Twelve Months Ending 2022-03
Book Value / Share 144.91 Trailing Twelve Months Ending 2022-03
Price to Book Value 3.62 Calculated using Price: 524.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 26.82 Cr. 268,195,172 Shares
FaceValue 2
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.48%
1 Week
+9.90%
1 Month
+0.71%
3 Month
+11.94%
6 Month
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 17.43 18.36 4.87 3.03 5.24 2.92 2.23 13.40
Return on Capital Employed (%) 25.32 26.12 8.63 5.94 6.55 6.20 5.26 16.38
Return on Assets (%) 12.10 12.62 3.23 1.81 2.88 1.46 0.99 5.85

Balance Sheet View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 879 1,057 1,139 1,217 1,305 1,350 1,382 1,616
Non Curr. Liab. 118 189 242 432 676 1,009 1,300 1,586
Curr. Liab. 214 238 272 334 279 358 405 419
Minority Int. 1 0
Equity & Liab. 1,212 1,485 1,653 1,984 2,259 2,716 3,087 3,622
Non Curr. Assets 802 976 1,025 1,512 1,769 2,237 2,585 2,810
Curr. Assets 410 509 627 472 490 479 502 812
Misc. Exp. not W/O
Total Assets 1,212 1,485 1,653 1,984 2,259 2,716 3,087 3,622

Profit Loss View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 1,194 1,382 1,277 1,343 1,441 1,500 1,447 2,167
Other Income 36 45 67 49 65 44 31 39
Total Income 1,230 1,427 1,344 1,392 1,506 1,544 1,478 2,206
Total Expenditure -932 -1,081 -1,155 -1,218 -1,299 -1,309 -1,250 -1,709
PBIDT 299 347 189 174 207 235 228 497
Interest -9 -14 -23 -28 -21 -57 -73 -86
Depreciation -64 -70 -81 -86 -91 -115 -123 -130
Taxation -79 -92 -35 -27 -34 -28 -4 -84
Exceptional Items 0
PAT 147 170 51 33 61 36 29 196
Minority Interest 1 0
Share Associate 0 0 0
Other Related Items
Consolidated Net Profit 147 170 51 33 61 36 29 196
Adjusted EPS 6 7 2 1 2 1 1 8

Cash Flow View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 213 228 115 63 150 175 242 311
Cash Fr. Inv. -126 -241 -107 -69 -244 -87 -239 -421
Cash Fr. Finan. -87 -7 -6 9 113 -1 -81 160
Net Change 0 -20 2 3 19 87 -78 50
Cash & Cash Eqvt 62 43 44 47 66 148 69 119

Shareholding Pattern View Details >>

1 Qtrs 2022-12 (%)
Promoter 33.08
Public 66.92
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Announcements View Details >>

Fri, 31 Mar 2023
Closure of Trading Window
Dear Sir This is to inform you that as per SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code for prevention of Insider Trading the Trading Window for purchasing/selling or dealing in the Shares of the Company shall remain closed from Saturday 1st April 2023 and will open after 48 hours from the declaration of Financial Results of the Company for the Quarter and Financial Year ending March 31 2023.You are requested to take the above on record.
Mon, 27 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
This is with reference to the letter Ref. No.- GHL/2022-23/EXCH/022 dated 13th February 2023 wherein the Board of Directors of the Company has approved the binding Term Sheet for a new hospital at Indore on Operation & Management basis. In this regard the Board of Directors of the Company at its Board Meeting held today i.e. Monday 27th March 2023 has extended the validity of Term Sheet till June 23 2023 (earlier 60 days from date of execution) to execute necessary agreement subject to completion of due diligence. The Company has appointed a law firm JSA advocates & solicitors for the purposes of conducting the said due diligence and the same is underway.There are no changes in the disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 on February 13 2023 except above.
Mon, 27 Mar 2023
Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
This is with reference to the letter Ref. No.- GHL/2022-23/EXCH/022 dated 13th February 2023 wherein the Board of Directors of the Company has approved the binding Term Sheet for a new hospital at Indore on Operation & Management basis. In this regard the Board of Directors of the Company at its Board Meeting held today i.e. Monday 27th March 2023 has extended the validity of Term Sheet till June 23 2023 (earlier 60 days from date of execution) to execute necessary agreement subject to completion of due diligence. The Company has appointed a law firm JSA advocates & solicitors for the purposes of conducting the said due diligence and the same is underway.There are no changes in the disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 on February 13 2023 except above.

Technical Scans View Details >>

Fri, 31 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Global Health Ltd.

What is Global Health share price?
Can I buy Global Health shares now?
What is the Market Cap of Global Health?
What are the key metrics to analyse Global Health?
What is the 52 Week High and Low of Global Health?
What is the trend of Global Health share price?